Bevacizumab is primarily used to treat retinal diseases such as wet age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion by inhibiting abnormal blood vessel growth and leakage.
What is the primary use of Bevacizumab in ophthalmology?
Share This Story, Choose Your Platform!
About the Author: Staff Writer
World Eyecare Foundation staff writers are experienced eye care providers, researchers, academicians, industry leaders and practicing ophthalmologists and optometrist from around the world. Content may be generated by AI and is reviewed by the editorial team and specialists in the areas of publications.
Leave A Comment